Paper16808554
Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk.
Motsko SP and 6 others. Drug Saf, 2006. Cited by 69 papers, by iCite.
Cite this record
ConductScience Library. Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk. Papers, record 16808554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16808554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Inflammatory Agents, Non-Steroidal | Major topic |
| Cardiovascular Diseases | Major topic |
| Cyclooxygenase 2 Inhibitors | Major topic |
| Lactones | Major topic |
| Pyrazoles | Major topic |
| Sulfonamides | Major topic |
| Sulfones | Major topic |
| Age Factors | |
| Celecoxib | |
| Cohort Studies | |
| Etodolac | |
| Female | |
| Humans | |
| Ibuprofen | |
| Male | |
| Middle Aged | |
| Naproxen | |
| Time Factors | |
| United States | |
| Veterans |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15530895 | Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs. | Atherosclerosis | 2004 | https://conductscience.org/library/papers/15530895 | PubMed |
| 2 | 15809459 | The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults. | Ann Intern Med | 2005 | https://conductscience.org/library/papers/15809459 | PubMed |
| 3 | 15713943 | Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15713943 | PubMed |
| 4 | 9018214 | Where do elderly veterans obtain care for acute myocardial infarction: Department of Veterans Affairs or Medicare? | Health Serv Res | 1997 | https://conductscience.org/library/papers/9018214 | PubMed |
| 5 | 10491245 | Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database. | J Gen Intern Med | 1999 | https://conductscience.org/library/papers/10491245 | PubMed |
| 6 | 16524325 | Cardiovascular events associated with long-term use of celecoxib, rofecoxib and meloxicam in Taiwan: an observational study. | Drug Saf | 2006 | https://conductscience.org/library/papers/16524325 | PubMed |
| 7 | 10979111 | Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. | JAMA | 2000 | https://conductscience.org/library/papers/10979111 | PubMed |
| 8 | 15713945 | Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15713945 | PubMed |
| 9 | 15853444 | Incidence of thrombotic cardiovascular events in patients taking celecoxib compared with those taking rofecoxib: interim results from the New Zealand Intensive Medicines Monitoring Programme. | Drug Saf | 2005 | https://conductscience.org/library/papers/15853444 | PubMed |
| 10 | 14668809 | COX-2 and beyond: Approaches to prostaglandin inhibition in human disease. | Nat Rev Drug Discov | 2003 | https://conductscience.org/library/papers/14668809 | PubMed |
| 11 | 11435450 | Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. | J Clin Invest | 2001 | https://conductscience.org/library/papers/11435450 | PubMed |
| 12 | 11160644 | Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. | J Pharmacol Exp Ther | 2001 | https://conductscience.org/library/papers/11160644 | PubMed |
| 13 | 12086701 | Expression of COX-1 and COX-2 mRNAs in atherosclerotic plaques. | Exp Gerontol | 2002 | https://conductscience.org/library/papers/12086701 | PubMed |
| 14 | 15582059 | Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. | Lancet | 2004 | https://conductscience.org/library/papers/15582059 | PubMed |
| 15 | 10952950 | Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. | Circulation | 2000 | https://conductscience.org/library/papers/10952950 | PubMed |
| 16 | 11696466 | Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib. | Circulation | 2001 | https://conductscience.org/library/papers/11696466 | PubMed |
| 17 | 11304662 | Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients. | Am J Ther | 2001 | https://conductscience.org/library/papers/11304662 | PubMed |
| 18 | 11717412 | A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11717412 | PubMed |
| 19 | 16119973 | A comparison of reported gastrointestinal and thromboembolic events between rofecoxib and celecoxib using observational data. | Drug Saf | 2005 | https://conductscience.org/library/papers/16119973 | PubMed |
| 20 | 15096449 | Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. | Circulation | 2004 | https://conductscience.org/library/papers/15096449 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38505473 | Cardiovascular Safety of Celecoxib after Cardiac Surgery with Cardiopulmonary Bypass: A Retrospective Cohort Study. | Ann Clin Epidemiol | 2021 | https://conductscience.org/library/papers/38505473 | PubMed |
| 35958187 | Comparison of Absolute Expression and Turnover Number of COX-1 and COX-2 in Human and Rodent Cells and Tissues. | J Inflamm Res | 2022 | https://conductscience.org/library/papers/35958187 | PubMed |
| 33879221 | Effect of acupotomy in knee osteoarthritis patients: study protocol for a randomized controlled trial. | Trials | 2021 | https://conductscience.org/library/papers/33879221 | PubMed |
| 33145451 | Evaluation of efficacy and safety of a novel lipogel containing diclofenac: A randomized, placebo controlled, double-blind clinical trial in patients with signs and symptoms of osteoarthritis. | Contemp Clin Trials Commun | 2020 | https://conductscience.org/library/papers/33145451 | PubMed |
| 31831964 | An open-label, prospective, multicenter, clinical study to evaluate efficacy of Ayuartis capsules in patients suffering from osteoarthritis of the knee(s). | Ayu | 2019 | https://conductscience.org/library/papers/31831964 | PubMed |
| 28664355 | Using Multiple Pharmacovigilance Models Improves the Timeliness of Signal Detection in Simulated Prospective Surveillance. | Drug Saf | 2017 | https://conductscience.org/library/papers/28664355 | PubMed |
| 25884765 | Model-based prediction of the acute and long-term safety profile of naproxen in rats. | Br J Pharmacol | 2015 | https://conductscience.org/library/papers/25884765 | PubMed |
| 24748817 | Clinical trial data in support of changing guidelines in osteoarthritis treatment. | J Pain Res | 2014 | https://conductscience.org/library/papers/24748817 | PubMed |
| 24444047 | Evolving guidelines in the use of topical nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis. | BMC Musculoskelet Disord | 2014 | https://conductscience.org/library/papers/24444047 | PubMed |
| 23204844 | Long-term tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities. | Clin Interv Aging | 2012 | https://conductscience.org/library/papers/23204844 | PubMed |
| 23179898 | COX-2 inhibitor and non-selective NSAID use in those at increased risk of NSAID-related adverse events: a retrospective database study. | Drugs Aging | 2013 | https://conductscience.org/library/papers/23179898 | PubMed |
| 22861669 | A pathway to improved prospective observational post-authorization safety studies. | Drug Saf | 2012 | https://conductscience.org/library/papers/22861669 | PubMed |
| 22257309 | Influence of the drug exposure definition on the assessment of the antipsychotic metabolic impact in patients initially treated with mood-stabilizers. | Br J Clin Pharmacol | 2012 | https://conductscience.org/library/papers/22257309 | PubMed |
| 22076115 | Topical nonsteroidal anti-inflammatory drugs for management of osteoarthritis in long-term care patients. | Ther Clin Risk Manag | 2011 | https://conductscience.org/library/papers/22076115 | PubMed |
| 21975789 | Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity. | Cochrane Database Syst Rev | 2011 | https://conductscience.org/library/papers/21975789 | PubMed |
| 21770475 | Topical therapies for osteoarthritis. | Drugs | 2011 | https://conductscience.org/library/papers/21770475 | PubMed |
| 21174485 | Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials. | Drugs Aging | 2011 | https://conductscience.org/library/papers/21174485 | PubMed |
| 20883058 | Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult? | Drugs Aging | 2010 | https://conductscience.org/library/papers/20883058 | PubMed |
| 20696045 | Role of COX-2 in cough reflex sensitivity to inhaled capsaicin in patients with sinobronchial syndrome. | Cough | 2010 | https://conductscience.org/library/papers/20696045 | PubMed |
| 20064249 | Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis. | Arthritis Res Ther | 2010 | https://conductscience.org/library/papers/20064249 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16808554
GET https://conductscience.org/api/papers/v1/16808554/references?page=2